Copyright © 2020 | CLEAR Initiative | All Rights Reserved | Website by Divigner
CLEAR Initiative
- CRSwNP affects 1%–4% of the general population
- CRSwNP affects 25%–30% of patients with chronic rhinosinusitis
- Average age of onset: 42 years
- CRSwNP can cause long-term symptoms: nasal obstruction, post-nasal drip, loss of smell, and discharge
The pathophysiology of CRSwNP is associated with local and systemic inflammation, with ongoing symptoms of nasal congestion, rhinorrhea, and loss of smell. These symptoms result in a significant burden on patients.
Our CLEAR program is an online tool that aims to provide clinicians and patients with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for individuals with CRSwNP. Our goal is to provide information that empowers clinicians and patients to speak openly about treatment decisions and improve the standard of care for patients with this challenging disease.
Thank you for visiting our website. We invite you to explore the Clinician Toolkit and Patient Toolkit links as well as our pages on CME events, a poster portal to create your own poster, links to animated videos, and much more!
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM).
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Copyright © 2019 | CLEAR Initiative | All Rights Reserved | Website by Divigner